Opioid Prescribing in Cancer Patients: Building Trust
October 25, 2018
7:00–8:00 pm EST / 6:00–7:00 pm CDT
Statement of Need/Activity Purpose
Recent guidelines for both cancer and non-cancer patients recommend incorporating risk assessment tools in the clinician’s pain assessment process. This is a new practice recommendation and a literature review is needed to review the risk assessment and management tools to be used in the cancer population. In addition, clinicians require guidance to interpret the results of these risk management tools and how the results impact treatment plans.
- State the components of a comprehensive pain assessment for cancer patients based on the current guidelines.
- Review available opioid risk assessment tools and the evidence for use in cancer patients.
- Given a patient case, interpret an opioid risk assessment result and develop a pain management treatment plan based on the result.
Dr. Diana Berescu, PharmD BCPS
Pain and Palliative Care Pharmacy Specialist
University of Maryland Medical Center
Dr. Diana Berescu received her Doctor of Pharmacy from the University of Toronto and completed her PGY1 in Pharmacy Practice at Howard County General Hospital. She recently completed her PGY2 Pain and Palliative Care Pharmacy Resident at The Johns Hopkins Hospital where she gained valuable experience in acute and chronic pain management therapies in both the inpatient and outpatient setting. She recently introduced a new member to her family and is on leave with her new son. She will be starting at the University of Maryland Medical Center as the Pain and Palliative Care Pharmacy Specialist in the coming year. Her interests include the safe and effective use of non-opioid medications. As well, she is particularly interested in patient education about pain management and the development of trust in the patient-provider relationship.
This activity is intended for Hematology/Oncology pharmacists. This activity has been approved for 1.00 contact hours (.10CEUs) under the ACPE universal activity number # 0465-0000-18-075-L04-P.
HOPA Member ‒ $20
Nonmember ‒ $40
The Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. A statement of credit will be issued only upon completion of the post-activity evaluation form and post-test.
Handouts for the webinar will be emailed to you 1-2 business days prior to the event.